Page last updated: 2024-12-08
scorodite
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 177152 |
MeSH ID | M0544815 |
Synonyms (8)
Synonym |
---|
16103-66-5 |
scorodite |
iron(3+) arsenate hydrate (1:1:2) |
20909-44-8 |
iron(3+) arsorate--water (1/1/2) |
DTXSID50936441 |
iron(3+);arsorate;dihydrate |
iron arsenate dihydrate |
Research Excerpts
Overview
Scorodite is an arsenic mineral with the chemical formula FeAsO(4)*2H(2)O. It is used for arsenic removal from industrial wastewaters and mine tailings.
Excerpt | Reference | Relevance |
---|---|---|
"Scorodite is an important mineral not only for arsenic (As) removal from industrial wastewaters but also in the mobility and final fate of As in waste rocks, contaminated soils and sediments, and mine tailings. " | ( Hematite-catalysed scorodite formation as a novel arsenic immobilisation strategy under ambient conditions. Corpuz, RD; Hiroyoshi, N; Igarashi, T; Ito, M; Tabelin, CB; Villacorte-Tabelin, M, 2019) | 2.29 |
"Scorodite is an arsenic mineral with the chemical formula FeAsO(4)*2H(2)O. " | ( Biogenic scorodite crystallization by Acidianus sulfidivorans for arsenic removal. Buisman, CJ; Gonzalez-Contreras, P; van der Weijden, R; Weijma, J, 2010) | 2.22 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (19)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 15 (78.95) | 24.3611 |
2020's | 4 (21.05) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 44.76
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (44.76) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 19 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |